The Institute of Cancer Research, shared a post on LinkedIn:
“Happy to highlight the British Society of Haematology BSH / UK Myeloma Society UKMS Good Practice Paper on Diagnosis and initial treatment of high-risk myeloma.
It is written with access challenges for patients to diagnostics and treatments in mind and can hopefully support access discussions in this context.
Also, it opens a future perspective on a route to safer treatment de-escalation for non-high-risk myeloma patients through comprehensive baseline diagnostics.”
Authors: Martin Kaiser, Guy Pratt, Ceri Bygrave, Kristian Bowles, Simon Stern, Matthew Jenner, and the BSH Committee.